Sheng Ding
About Sheng Ding
Sheng Ding is a prominent scientist and entrepreneur, currently serving as Co-Founder at Tenaya Therapeutics and Institute Director at the Global Health Drug Discovery Institute in Beijing. He has a strong background in pharmaceutical chemistry and has co-founded multiple biotech companies, holding over 30 patents and publishing extensively in the field.
Work at Tenaya Therapeutics
Sheng Ding has served as Co-Founder at Tenaya Therapeutics since 2016. The company focuses on developing innovative therapies for heart disease and other serious conditions. Under his leadership, Tenaya Therapeutics has advanced its research initiatives and contributed to the biotechnology sector's efforts in regenerative medicine.
Current Role at Global Health Drug Discovery Institute
Since 2016, Sheng Ding has held the position of Institute Director at the Global Health Drug Discovery Institute (GHDDI) in Beijing City, China. In this role, he oversees research and development efforts aimed at discovering new drug candidates to address global health challenges. His leadership at GHDDI emphasizes collaboration and innovation in drug discovery.
Education and Expertise
Sheng Ding earned a Bachelor of Science in chemistry with honors from Caltech. He later pursued a Doctor of Philosophy (Ph.D.) in chemistry at The Scripps Research Institute, completing his studies in 2003. His academic background provides a strong foundation for his work in pharmaceutical chemistry and stem cell biology.
Professional Background
Sheng Ding has an extensive professional background in academia and biotechnology. He served as an Assistant Professor and later as an Associate Professor of Chemistry at The Scripps Research Institute from 2003 to 2011. He is currently a Professor of Pharmaceutical Chemistry at the University of California, San Francisco, where he continues to contribute to the field through research and education.
Achievements and Contributions
Sheng Ding has published over 130 research articles, reviews, and book chapters, showcasing his contributions to the scientific community. He holds over 30 patents related to his work in chemical approaches to stem cell biology and regeneration. His recognition as a William K. Bowes, Jr. Distinguished Investigator at the Gladstone Institute of Cardiovascular Disease highlights his impact in the field.